A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
Treatment can no longer be one dimensional.
This complimentary event will give attendees insights on the market landscape and potential areas of opportunity.
The transition to digital in healthcare is happening at a fast pace.
Medtech decision makers must accurately predict future trends in order to chart the best future directions and identify the most advantageous areas for business investment.
Three startup companies have made strong strides in helping patients with autism spectrum disorder.
The agency granted its first approval order under the humanitarian device exemption in spinal pediatrics in the last 15 years.
The agency is encouraging the industry to develop sterilization approaches that either don’t rely on ethylene oxide or reduce emissions from this method.